LITHIUM, ELEMENTAL
Suicidal Ideation and Behavior
NeuroRx, Inc.Small moleculePhase 2/3Active
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Suicidal Ideation and Behavior cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nrx-101 NeuroRx, Inc. | Phase 2/3 | B |
Lurasidone NeuroRx, Inc. | Phase 2/3 | B |
Same molecule, other indications
LITHIUM, ELEMENTAL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →